Medicare Coverage for Depression & Anxiety: 2025 Guide

Depression affects approximately 1 in 5 older adults but is vastly underdiagnosed and undertreated in the Medicare population. Medicare covers comprehensive depression and anxiety care — including free screening, therapy at parity with medical visits, and protected-class medications that plans cannot arbitrarily exclude. Understanding what's covered removes a common barrier to seeking help.

Depression & Anxiety Coverage at a Glance

Free Depression Screening Under Medicare

Medicare Part B covers annual depression screening at no cost to you — $0 copay, $0 deductible — when performed at your Annual Wellness Visit (AWV) or as a standalone preventive service. This applies to all Medicare beneficiaries, regardless of whether they have depression symptoms.

Medicare also covers alcohol misuse screening at $0, along with brief counseling (up to 4 sessions per year) if your screening is positive. Because alcohol misuse and depression are closely linked in older adults, these two screenings together provide an important window into mental health that many beneficiaries overlook.

If you haven't had an Annual Wellness Visit this year, scheduling one is the fastest way to access both of these free preventive screenings simultaneously.

Mental Health Parity: Therapy at the Same 20% as Medical Care

Before the Affordable Care Act's 2014 reforms took full effect in Medicare, outpatient mental health visits cost beneficiaries 50% coinsurance — more than double the rate for comparable medical visits. That inequity is gone. Today, mental health therapy is covered at exactly the same 20% coinsurance as a visit to your cardiologist or gastroenterologist.

This parity applies to:

• Individual therapy sessions
• Group therapy sessions
• Psychiatric evaluations and medication management
• Telehealth behavioral health visits
• IOP and partial hospitalization programs

There is no annual limit on medically necessary outpatient therapy sessions. If your provider documents that continued treatment is clinically indicated, Medicare will continue to cover it at 20% indefinitely.

Which Providers Can Treat Depression and Anxiety Under Medicare?

Medicare covers services from a range of qualified mental health professionals:

• Psychiatrists (MD/DO) — Can diagnose, prescribe medications, and provide therapy
• Psychologists (PhD/PsyD) — Can provide therapy and psychological testing; cannot prescribe in most states
• Licensed Clinical Social Workers (LCSW/LICSW) — Individual and group therapy
• Psychiatric Mental Health Nurse Practitioners (PMHNP) — Therapy and prescribing
• Licensed Professional Counselors (LPC/LPCC) — Covered as of January 2024
• Marriage and Family Therapists (LMFT/MFT) — Covered as of January 2024

All providers must be enrolled in Medicare and billing directly. To find a Medicare-participating mental health provider in your area, visit Medicare.gov/care-compare or call 1-800-MEDICARE.

Telehealth for Depression and Anxiety: From Your Home

Medicare permanently expanded telehealth for behavioral health, allowing you to attend therapy or psychiatric visits by video from your own home — with no geographic restriction. This is a major departure from most other Medicare telehealth services, which still require patients to be in designated rural areas.

Key telehealth details for mental health:

• Audio-video and audio-only: Both are allowed for mental health under Medicare. If you don't have reliable video access, a telephone call with your provider is still covered.
• 2025 in-person requirement: For ongoing telehealth mental health care, Medicare requires an in-person visit with the provider within the first 6 months of establishing telehealth care. This aims to ensure that patients and providers have at least one face-to-face encounter before relying entirely on remote visits.
• Cost: Same as in-person — 20% coinsurance after the Part B deductible.

Antidepressants and Anti-Anxiety Medications: Protected Drug Class

Medicare Part D designates antidepressants as a protected drug class — meaning every Part D plan is required to cover all clinically available antidepressants, regardless of the plan's specific formulary. This is one of only six protected classes in Medicare (others include antipsychotics, anticonvulsants, antiretrovirals, antineoplastics, and immunosuppressants for transplant).

SSRIs (Selective Serotonin Reuptake Inhibitors)

SSRIs are the most commonly prescribed antidepressants for both depression and anxiety disorders. All are available as low-cost generics under Part D:

• Sertraline (generic Zoloft) — Tier 1; typically $0–$5/month
• Escitalopram (generic Lexapro) — Tier 1; typically $0–$5/month
• Fluoxetine (generic Prozac) — Tier 1; typically $0–$5/month
• Citalopram (generic Celexa) — Tier 1; typically $0–$5/month
• Paroxetine (generic Paxil) — Tier 1; typically $0–$5/month

SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)

• Duloxetine (generic Cymbalta) — Tier 1–2; typically $0–$10/month; also approved for chronic pain and GAD
• Venlafaxine (generic Effexor) — Tier 1–2; typically $0–$10/month
• Desvenlafaxine (generic Pristiq) — Tier 2; typically $5–$15/month

Other Antidepressants

• Bupropion (generic Wellbutrin) — Tier 1; $0–$5/month; also approved for smoking cessation; good option for patients concerned about weight gain or sexual side effects
• Mirtazapine (generic Remeron) — Tier 1; $0–$5/month; useful when insomnia or appetite loss accompanies depression

Anxiety-Specific Medications

• Buspirone — Tier 1; $0–$5/month; non-addictive anxiolytic approved for generalized anxiety disorder (GAD); preferred over benzodiazepines for long-term use in older adults
• Pregabalin (generic Lyrica) — Tier 3; covered Part D; approved for GAD and also for fibromyalgia and neuropathic pain
• Gabapentin — Tier 1; $0–$5/month; sometimes prescribed off-label for anxiety; covered Part D
• Benzodiazepines (alprazolam, lorazepam, clonazepam, diazepam) — Covered under Part D since 2013; Tier 1 generics, $0–$5/month. Important caveat: benzodiazepines are appropriate for short-term use but carry significant risks in older adults, including increased fall risk, cognitive impairment, and dependence. Many geriatric specialists recommend deprescribing (gradual tapering) of benzodiazepines in Medicare-age patients when possible.

The 2025 $2,000 Part D out-of-pocket cap means that even if you take multiple medications, your annual Part D costs are capped at $2,000 — providing important protection for people with complex medication regimens.

Anxiety Disorders Covered by Medicare

Medicare covers treatment for all clinically diagnosed anxiety disorders under the same Part B framework as depression:

• Generalized Anxiety Disorder (GAD)
• Panic Disorder
• Social Anxiety Disorder
• Post-Traumatic Stress Disorder (PTSD)
• Obsessive-Compulsive Disorder (OCD)
• Specific Phobias

A formal diagnosis is required for Medicare to cover treatment. Your primary care provider or a mental health specialist can provide this diagnosis. Therapy approaches including cognitive-behavioral therapy (CBT), which has strong evidence for both depression and anxiety, are covered.

Treatment-Resistant Depression: TMS and ECT

For patients whose depression does not respond adequately to antidepressant medications, Medicare covers two advanced treatment options:

Transcranial Magnetic Stimulation (TMS)

TMS is a non-invasive procedure that uses magnetic pulses to stimulate nerve cells in the brain regions involved in mood regulation. Medicare Part B covers TMS when:

• The patient has a primary diagnosis of major depressive disorder (MDD)
• The patient has not responded to at least one adequate trial of an antidepressant medication
• The treatment is provided by a qualified physician or mental health professional

A full TMS course typically involves sessions 5 days per week for 4–6 weeks (approximately 20–30 sessions). You pay 20% coinsurance after the Part B deductible for each session.

Electroconvulsive Therapy (ECT)

ECT remains one of the most effective treatments available for severe, treatment-resistant depression. It involves brief electrical stimulation of the brain under general anesthesia. Medicare covers ECT under Part B (outpatient) at 20% coinsurance, or under Part A (inpatient) with the standard hospital deductible when hospitalization is required. ECT is typically used for severe depression, depression with psychotic features, or cases where rapid response is needed.

Intensive Outpatient and Partial Hospitalization Programs

When weekly therapy isn't sufficient but hospitalization isn't required, Medicare covers two higher-intensity levels of outpatient care:

• Intensive Outpatient Program (IOP): Typically 3–5 days per week, 3 hours per day. Provides structured group therapy, individual therapy, psychoeducation, and skill-building. Appropriate for moderate depression or anxiety that isn't responding to standard outpatient care. Covered at 20% under Part B.
• Partial Hospitalization Program (PHP): Hospital-based program providing more intensive services than IOP — typically 5–6 hours per day, 5 days per week. Often used as a step-down from inpatient hospitalization or as an alternative to hospitalization for acute but not dangerous symptoms. Covered at 20% under Part B.

Inpatient Psychiatric Coverage for Severe Depression

For severe depression requiring hospitalization — including suicidal crises or complete inability to function — Medicare Part A covers inpatient psychiatric care with these key distinctions:

• Psychiatric unit in a general hospital: No lifetime day limit. Covered under standard Part A rules: $1,676 deductible per benefit period, then no coinsurance for days 1–60, $419/day for days 61–90, and $838/day for lifetime reserve days.
• Freestanding psychiatric hospital: Subject to a 190-day lifetime limit under Medicare. This limit is cumulative — once used, it cannot be renewed. General hospital psychiatric units are preferred when this limit is a concern.

Frequently Asked Questions